Roche's deal for InterMune is one of the few this year that returns to the traditional model of big pharma buying smaller biotech.» Read More
Johnson & Johnson posted better-than-expected first-quarter earnings on Tuesday, sending its shares higher, as aggressive cost cutting helped offset plunging sales of anemia drugs hit by safety concerns and medicines facing generic competition.
Dow component and healthcare conglomerate (drugs, consumer products, medical devices) Johnson & Johnson beat and boosted. That's Wall Street jargon for earnings coming in higher than expectations and the guidance for the rest of the year being raised. So, why did the stock go down?
Stocks traded mixed Tuesday as not-horrible earnings failed to quell market jitters about earnings.
Stocks opened higher Tuesday after a tame core inflation reading, a better-than-expected manufacturing report and news of a Delta-Northwest deal.
Futures actually moved up at 8:30 ET, despite PPI much stronger than anticipated (core PPI was in-line, apparently because car and truck prices were dropping; the NY Empire State Index was stronger than expected).
In Monday’s Web Extra the traders reveal how to play Johnson & Johnson, CSX Corp. as well as a second airline merger.
Can we please get some upside earnings reports this quarter? No financial exposure here. Instead, this Dow Industrial has plenty of overseas business to be helped by the weaker dollar and guardedly optimistic expectations for key business segments.
To give investors an edge, CNBC asked market experts to share their best retail plays.
Find out if these viewers are investing according to Mad Money's most important rule.
A steady stream of downbeat news seemed to leave the market unmoved for most of the week -- until the bluest of the blue chips, General Electric, posted first-quarter earnings that missed Wall Street expectations by seven cents per share, and lowered its full-year guidance.
With other blue-chip companies due to report earnings in the coming week, GE's disappointing results fueled worries that the bad news may be just beginning.
A double helping of economic data and first-quarter earnings reports will flood the zone next week, but it's the corporate earnings that will drive stocks and give a better picture of where the economy is going. If GE's bombshell earnings miss is an indicator, the news will be as nasty as traders expect.
In Friday’s Web Extra find out how the traders are playing the earnings deluge coming in the week ahead.
While passing the Olympic torch has become a focal point for demonstrations over China's human rights record, major sponsors of the games aren't expected to flame out over the controversy.
Dow Jones has created a Summer Games Index to track the companies involved in the Olympics. How is it reacting to the protests?
Plus, Intel drags down tech, breaking news from American Airlines and UPS and much more.
After a rough start, top investment officers are looking for gradual improvement as 2008 goes on. Harbor Advisory's Jack DeGan is among them, and he won't sugar-coat the current situation.
The Star-Ledger of New Jersey this weekend did a story that I think provides the best insight and backstory about what happened last week at the highest levels of Schering-Plough.CEO Fred Hassan was in Miami when doctors dropped the bomb on Vytorin and Zetia at the American College of Cardiology meeting.
CEO Fred Hassan updates investors on his company's plans to rebound from the Vytorin debacle.
Microsoft vs. Apple is just one of the exciting match-ups in this round of the Fast Money Madness tournament. Find out which companies make it to the Final Four.